Tokyo Tape
Sign in
← MedPeer

Quarterly report · Q2

6095.TEDINET S100QPSY
Period2022-10-01 → 2023-03-31
Filed2023-05-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥7.1bn2022-10-01 → 2023-03-31Cons.Net sales
Revenue¥8.5bn2021-10-01 → 2022-09-30Cons.Net sales (5-year summary)
Revenue¥4.4bn2021-10-01 → 2022-03-31Cons.Net sales
Operating income¥717m2022-10-01 → 2023-03-31Cons.Operating income
Operating income¥867m2021-10-01 → 2022-03-31Cons.Operating income
Ordinary income¥735m2022-10-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥1.1bn2021-10-01 → 2022-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥890m2021-10-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥735m2022-10-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥890m2021-10-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥380m2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥812m2021-10-01 → 2022-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥599m2021-10-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥391m2022-10-01 → 2023-03-31Cons.Profit loss
Net income¥618m2021-10-01 → 2022-03-31Cons.Profit loss
Total assets¥14.5bnat 2023-03-31Cons.Assets
Total assets¥9.4bnat 2022-09-30Cons.Assets
Total assets¥9.2bnat 2022-03-31Cons.Total assets (5-year summary)
Total liabilities¥5.8bnat 2023-03-31Cons.Liabilities
Total liabilities¥1.5bnat 2022-09-30Cons.Liabilities
Net assets / equity¥8.6bnat 2023-03-31Cons.Net assets
Net assets / equity¥7.9bnat 2022-09-30Cons.Net assets
Net assets / equity¥7.6bnat 2022-03-31Cons.Net assets (5-year summary)
Cash and deposits¥5.7bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥6.1bnat 2022-09-30Cons.Cash and deposits
Cash & equivalents¥5.7bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥6.1bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥6.1bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.7bnat 2021-09-30dCons.Cash and cash equivalents
Operating cash flow¥122m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥853m2021-10-01 → 2022-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥538m2021-10-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥4.8bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥423m2021-10-01 → 2022-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥78m2021-10-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Financing cash flow¥4.2bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥7m2021-10-01 → 2022-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥21m2021-10-01 → 2022-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥17.422022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥37.622021-10-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.742021-10-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.572022-01-01 → 2022-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥17.052022-10-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥35.782021-10-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.262021-10-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio57.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio81.1%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio79.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-03-31−¥657m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥2m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥1.3bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥243m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥240m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥3m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2022-10-01 → 2023-03-31−¥40m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥300,000
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥94m
—segment totalrevenue2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue external2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue intersegment2022-10-01 → 2023-03-31¥5m
—segment totalsegment profit2022-10-01 → 2023-03-31¥1.4bn
Reconciling Itemsreconcilingrevenue2021-10-01 → 2022-03-31−¥7m
Reconciling Itemsreconcilingrevenue intersegment2021-10-01 → 2022-03-31−¥7m
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-03-31−¥645m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2021-10-01 → 2022-03-31¥3.2bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2021-10-01 → 2022-03-31¥3.2bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2021-10-01 → 2022-03-31¥2m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2021-10-01 → 2022-03-31¥1.3bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2021-10-01 → 2022-03-31¥202m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2021-10-01 → 2022-03-31¥199m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2021-10-01 → 2022-03-31¥3m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2021-10-01 → 2022-03-31¥30m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2021-10-01 → 2022-03-31¥1.0bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2021-10-01 → 2022-03-31¥1.0bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2021-10-01 → 2022-03-31¥3m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2021-10-01 → 2022-03-31¥137m
—segment totalrevenue2021-10-01 → 2022-03-31¥4.4bn
—segment totalrevenue external2021-10-01 → 2022-03-31¥4.4bn
—segment totalrevenue intersegment2021-10-01 → 2022-03-31¥7m
—segment totalsegment profit2021-10-01 → 2022-03-31¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 506
ItemContextValueUnit
Provision for point card certificates clCurrentQuarterInstant164571000JPY
Contract liabilitiesPrior1YearInstant159285000JPY
Contract liabilitiesCurrentQuarterInstant117780000JPY
Other clPrior1YearInstant220719000JPY
Other clCurrentQuarterInstant387562000JPY
Current liabilitiesPrior1YearInstant1280763000JPY
Current liabilitiesCurrentQuarterInstant2181176000JPY
Long term loans payablePrior1YearInstant67033000JPY
Long term loans payableCurrentQuarterInstant3464314000JPY
Asset retirement obligations nclPrior1YearInstant79123000JPY
Asset retirement obligations nclCurrentQuarterInstant87640000JPY
Deferred tax liabilitiesPrior1YearInstant57728000JPY
Deferred tax liabilitiesCurrentQuarterInstant48196000JPY
Net defined benefit liabilityPrior1YearInstant－JPY
Net defined benefit liabilityCurrentQuarterInstant56205000JPY
Other nclPrior1YearInstant3155000JPY
Other nclCurrentQuarterInstant2264000JPY
Noncurrent liabilitiesPrior1YearInstant207040000JPY
Noncurrent liabilitiesCurrentQuarterInstant3658620000JPY
LiabilitiesPrior1YearInstant1487804000JPY
LiabilitiesCurrentQuarterInstant5839797000JPY
Capital stockPrior1YearInstant2051041000JPY
Capital stockCurrentQuarterInstant2244624000JPY
Capital surplusPrior1YearInstant2306453000JPY
Capital surplusCurrentQuarterInstant2500036000JPY
Retained earningsPrior1YearInstant3236973000JPY
Retained earningsCurrentQuarterInstant3617384000JPY
Treasury stockPrior1YearInstant-644000JPY
Treasury stockCurrentQuarterInstant-711000JPY
Shareholders equityPrior1YearInstant7593823000JPY
Shareholders equityCurrentQuarterInstant8361333000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-11046000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-11693000JPY
Valuation and translation adjustmentsPrior1YearInstant-11046000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-11693000JPY
Subscription rights to sharesPrior1YearInstant9578000JPY
Subscription rights to sharesCurrentQuarterInstant8778000JPY
Non controlling interestsPrior1YearInstant270848000JPY
Non controlling interestsCurrentQuarterInstant281082000JPY
Net assetsPrior1YearInstant7863203000JPY
Net assetsCurrentQuarterInstant8639500000JPY
Liabilities and net assetsPrior1YearInstant9351008000JPY
Liabilities and net assetsCurrentQuarterInstant14479297000JPY
Net salesPrior1YTDDuration4440479000JPY
Net salesCurrentYTDDuration7129040000JPY
Cost of salesPrior1YTDDuration1688212000JPY
Cost of salesCurrentYTDDuration3603351000JPY
Gross profitPrior1YTDDuration2752266000JPY
Gross profitCurrentYTDDuration3525689000JPY
Selling general and administrative expensesPrior1YTDDuration1885407000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-09-30pass rounding
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2021-10-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2021-10-01/2022-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass